TickerFacts.

Biomerica Inc (BMRA): Cost of Revenue

Annual figures by period end, from SEC filings.

$4.09M
Year ended 2026-05-31
-5.8%
3-year compound annual growth
-9.8%
5-year compound annual growth
+1.2%
10-year compound annual growth
$15.89M2011-05-31: $3.37M2012-05-31: $3.78M2013-05-31: $4.05M2014-05-31: $3.45M2015-05-31: $3.42M2016-05-31: $3.62M2017-05-31: $3.77M2018-05-31: $3.81M2019-05-31: $3.91M2020-05-31: $4.95M2021-05-31: $6.83M2022-05-31: $15.89M2023-05-31: $4.89M2024-05-31: $4.80M2025-05-31: $4.81M2026-05-31: $4.09M$4.09M
2011-05-31 Cost of Revenue (USD) 2026-05-31
Period endedCost of RevenueChange YoYSource filing
2026-05-31$4.09M-15.0%2026-08-31, From 2025-06-01
2025-05-31$4.81M+0.2%2026-08-31, From 2024-06-01
2024-05-31$4.80M-1.8%2025-08-29, From 2023-06-01
2023-05-31$4.89M-69.2%2024-08-28, From 2022-06-01
2022-05-31$15.89M+132.6%2023-08-25, From 2021-06-01
2021-05-31$6.83M+37.9%2022-08-29, From 2020-06-01
2020-05-31$4.95M+26.8%2021-10-14, From 2019-06-01
2019-05-31$3.91M+2.6%2020-08-31, From 2018-06-01
2018-05-31$3.81M+1.1%2019-08-29, From 2017-06-01
2017-05-31$3.77M+4.3%2018-08-29, From 2016-06-01
2016-05-31$3.62M+5.7%2017-08-29, From 2015-06-01
2015-05-31$3.42M-0.9%2016-08-29, From 2014-06-01
2014-05-31$3.45M-14.7%2015-08-31, From 2013-06-01
2013-05-31$4.05M+6.9%2014-08-29, From 2012-06-01
2012-05-31$3.78M+12.2%2013-08-29, From 2011-06-01
2011-05-31$3.37Mn/a2012-08-29, From 2010-06-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Biomerica Inc (BMRA)2026-05-31$4.09M-15.0%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$1.75M+66.2%
Anbio Biotechnology (NNNN)2025-12-31$1.10M-52.0%
Aspira Women's Health Inc. (AWHL)2025-12-31$3.30M-10.9%
Celldex Therapeutics, Inc. (CLDX)2025-12-31$200.0K0.0%
Immucell Corp (ICCC)2025-12-31$16.20M-12.7%
Alpha Teknova, Inc. (TKNO)2025-12-31$27.08M-11.3%
Myriad Genetics Inc (MYGN)2025-12-31$247.90M-1.7%
Neogen Corp (NEOG)2026-05-31$461.90M-2.4%

Compare BMRA, IMDX, NNNN, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗